124 related articles for article (PubMed ID: 3188122)
1. Effect of the aminosteroid U74006F after cardiopulmonary arrest in dogs.
Natale JE; Schott RJ; Hall ED; Braughler JM; D'Alecy LG
Stroke; 1988 Nov; 19(11):1371-8. PubMed ID: 3188122
[TBL] [Abstract][Full Text] [Related]
2. The 21-aminosteroid U74006F reduces systemic lipid peroxidation, improves neurologic function, and reduces mortality after cardiopulmonary arrest in dogs.
Natale JE; Schott RJ; Hall ED; Braughler JM; D'Alecy LG
Prog Clin Biol Res; 1989; 308():891-6. PubMed ID: 2780736
[No Abstract] [Full Text] [Related]
3. Pretreatment with U74006F improves neurologic outcome following complete cerebral ischemia in dogs.
Perkins WJ; Milde LN; Milde JH; Michenfelder JD
Stroke; 1991 Jul; 22(7):902-9. PubMed ID: 1853410
[TBL] [Abstract][Full Text] [Related]
4. U74006F, a novel 21-aminosteroid, inhibits in vivo lipid peroxidation but fails to limit infarct size in a canine model of myocardial ischemia reperfusion.
Ovize M; de Lorgeril M; Ovize A; Ciavatti M; Delaye J; Renaud S
Am Heart J; 1991 Sep; 122(3 Pt 1):681-9. PubMed ID: 1877444
[TBL] [Abstract][Full Text] [Related]
5. Effects of U74006F on multifocal cerebral blood flow and metabolism after cardiac arrest in dogs.
Sterz F; Safar P; Johnson DW; Oku K; Tisherman SA
Stroke; 1991 Jul; 22(7):889-95. PubMed ID: 1853408
[TBL] [Abstract][Full Text] [Related]
6. Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of beagle dogs.
Matsui T; Asano T
Neurosurgery; 1994 Jun; 34(6):1035-9; discussion 1039. PubMed ID: 8084388
[TBL] [Abstract][Full Text] [Related]
7. 21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils.
Hall ED; Pazara KE; Braughler JM
Stroke; 1988 Aug; 19(8):997-1002. PubMed ID: 3400111
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of renal reperfusion injury in rats by the 21-aminosteroid U74006F.
Stanley JJ; Goldblum JR; Frank TS; Zelenock GB; D'Alecy LG
J Vasc Surg; 1993 Apr; 17(4):685-9. PubMed ID: 8464086
[TBL] [Abstract][Full Text] [Related]
9. Effect of the nonglucocorticoid 21-aminosteroid U74006F experimental cerebral vasospasm.
Vollmer DG; Kassell NF; Hongo K; Ogawa H; Tsukahara T
Surg Neurol; 1989 Mar; 31(3):190-4. PubMed ID: 2922661
[TBL] [Abstract][Full Text] [Related]
10. Effects of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia in cats.
Hall ED
J Neurosurg; 1988 Mar; 68(3):462-5. PubMed ID: 3343617
[TBL] [Abstract][Full Text] [Related]
11. Effect of 21-aminosteroid lipid peroxidation inhibitor, U74006F, in the rat middle cerebral artery occlusion model.
Umemura K; Wada K; Uematsu T; Mizuno A; Nakashima M
Eur J Pharmacol; 1994 Jan; 251(1):69-74. PubMed ID: 8137871
[TBL] [Abstract][Full Text] [Related]
12. The novel 21-aminosteroid U74006F attenuates cerebral edema and improves survival after brain injury in the rat.
McIntosh TK; Thomas M; Smith D; Banbury M
J Neurotrauma; 1992; 9(1):33-46. PubMed ID: 1619674
[TBL] [Abstract][Full Text] [Related]
13. Prevention of lipid peroxidation does not prevent oxidant-induced myocardial contractile dysfunction.
Kong Y; Lesnefsky EJ; Ye J; Horwitz LD
Am J Physiol; 1994 Dec; 267(6 Pt 2):H2371-7. PubMed ID: 7810737
[TBL] [Abstract][Full Text] [Related]
14. Effects of U74006F, a novel inhibitor of lipid peroxidation, in stunned reperfused canine myocardium.
Holzgrefe HH; Buchanan LV; Gibson JK
J Cardiovasc Pharmacol; 1990 Feb; 15(2):239-48. PubMed ID: 1689419
[TBL] [Abstract][Full Text] [Related]
15. Cardiopulmonary-cerebral resuscitation with 100% oxygen exacerbates neurological dysfunction following nine minutes of normothermic cardiac arrest in dogs.
Zwemer CF; Whitesall SE; D'Alecy LG
Resuscitation; 1994 Mar; 27(2):159-70. PubMed ID: 8086011
[TBL] [Abstract][Full Text] [Related]
16. Post-ischemic brain tissue alkalosis suppressed by U74006F.
Vande Linde AM; Chopp M; Lee SA; Schultz LR; Welch KM
J Neurol Sci; 1993 Jan; 114(1):36-9. PubMed ID: 8433095
[TBL] [Abstract][Full Text] [Related]
17. Effects of the 21-aminosteroid U74006F on experimental head injury in mice.
Hall ED; Yonkers PA; McCall JM; Braughler JM
J Neurosurg; 1988 Mar; 68(3):456-61. PubMed ID: 3343616
[TBL] [Abstract][Full Text] [Related]
18. Blocking weight-induced spinal cord injury in rats: therapeutic effect of the 21-aminosteroid U74006F.
Holtz A; Gerdin B
J Neurotrauma; 1991; 8(4):239-45. PubMed ID: 1803032
[TBL] [Abstract][Full Text] [Related]
19. A dosage study of the effect of the 21-aminosteroid U74006F on chronic cerebral vasospasm in a primate model.
Kanamaru K; Weir BK; Findlay JM; Grace M; Macdonald RL
Neurosurgery; 1990 Jul; 27(1):29-38. PubMed ID: 2377279
[TBL] [Abstract][Full Text] [Related]
20. Correlation between attenuation of posttraumatic spinal cord ischemia and preservation of tissue vitamin E by the 21-aminosteroid U74006F: evidence for an in vivo antioxidant mechanism.
Hall ED; Yonkers PA; Horan KL; Braughler JM
J Neurotrauma; 1989; 6(3):169-76. PubMed ID: 2810381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
